These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 24680889)

  • 1. De novo loss-of-function mutations in SETD5, encoding a methyltransferase in a 3p25 microdeletion syndrome critical region, cause intellectual disability.
    Grozeva D; Carss K; Spasic-Boskovic O; Parker MJ; Archer H; Firth HV; Park SM; Canham N; Holder SE; Wilson M; Hackett A; Field M; Floyd JA; ; Hurles M; Raymond FL
    Am J Hum Genet; 2014 Apr; 94(4):618-24. PubMed ID: 24680889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss-of-function variants of SETD5 cause intellectual disability and the core phenotype of microdeletion 3p25.3 syndrome.
    Kuechler A; Zink AM; Wieland T; Lüdecke HJ; Cremer K; Salviati L; Magini P; Najafi K; Zweier C; Czeschik JC; Aretz S; Endele S; Tamburrino F; Pinato C; Clementi M; Gundlach J; Maylahn C; Mazzanti L; Wohlleber E; Schwarzmayr T; Kariminejad R; Schlessinger A; Wieczorek D; Strom TM; Novarino G; Engels H
    Eur J Hum Genet; 2015 Jun; 23(6):753-60. PubMed ID: 25138099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. De novo SETD5 loss-of-function variant as a cause for intellectual disability in a 10-year old boy with an aberrant blind ending bronchus.
    Green C; Willoughby J; ; Balasubramanian M
    Am J Med Genet A; 2017 Dec; 173(12):3165-3171. PubMed ID: 28905509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in Histone Acetylase Modifier BRPF1 Cause an Autosomal-Dominant Form of Intellectual Disability with Associated Ptosis.
    Mattioli F; Schaefer E; Magee A; Mark P; Mancini GM; Dieterich K; Von Allmen G; Alders M; Coutton C; van Slegtenhorst M; Vieville G; Engelen M; Cobben JM; Juusola J; Pujol A; Mandel JL; Piton A
    Am J Hum Genet; 2017 Jan; 100(1):105-116. PubMed ID: 27939639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expansion and further delineation of the SETD5 phenotype leading to global developmental delay, variable dysmorphic features, and reduced penetrance.
    Powis Z; Farwell Hagman KD; Mroske C; McWalter K; Cohen JS; Colombo R; Serretti A; Fatemi A; David KL; Reynolds J; Immken L; Nagakura H; Cunniff CM; Payne K; Barbaro-Dieber T; Gripp KW; Baker L; Stamper T; Aleck KA; Jordan ES; Hersh JH; Burton J; Wentzensen IM; Guillen Sacoto MJ; Willaert R; Cho MT; Petrik I; Huether R; Tang S
    Clin Genet; 2018 Apr; 93(4):752-761. PubMed ID: 28881385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SETD5 loss-of-function mutation as a likely cause of a familial syndromic intellectual disability with variable phenotypic expression.
    Szczałuba K; Brzezinska M; Kot J; Rydzanicz M; Walczak A; Stawiński P; Werner B; Płoski R
    Am J Med Genet A; 2016 Sep; 170(9):2322-7. PubMed ID: 27375234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A de novo 10.1-Mb 3p25 terminal deletion including SETD5 in a patient with ptosis and psychomotor retardation.
    Yagasaki H; Toda T; Koizumi K; Sugiyama T; Ohyama T; Hoshiai M; Nakane T; Sugita K
    Pediatr Neonatol; 2018 Jun; 59(3):319-321. PubMed ID: 28951171
    [No Abstract]   [Full Text] [Related]  

  • 8. Genotype-phenotype evaluation of MED13L defects in the light of a novel truncating and a recurrent missense mutation.
    Asadollahi R; Zweier M; Gogoll L; Schiffmann R; Sticht H; Steindl K; Rauch A
    Eur J Med Genet; 2017 Sep; 60(9):451-464. PubMed ID: 28645799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SETD5 gene variant associated with mild intellectual disability - a case report.
    Stur E; Soares LA; Louro ID
    Genet Mol Res; 2017 May; 16(2):. PubMed ID: 28549204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic variations on SETD5 underlying autistic conditions.
    Fernandes IR; Cruz ACP; Ferrasa A; Phan D; Herai RH; Muotri AR
    Dev Neurobiol; 2018 May; 78(5):500-518. PubMed ID: 29484850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. De novo loss-of-function mutations in WAC cause a recognizable intellectual disability syndrome and learning deficits in Drosophila.
    Lugtenberg D; Reijnders MR; Fenckova M; Bijlsma EK; Bernier R; van Bon BW; Smeets E; Vulto-van Silfhout AT; Bosch D; Eichler EE; Mefford HC; Carvill GL; Bongers EM; Schuurs-Hoeijmakers JH; Ruivenkamp CA; Santen GW; van den Maagdenberg AM; Peeters-Scholte CM; Kuenen S; Verstreken P; Pfundt R; Yntema HG; de Vries PF; Veltman JA; Hoischen A; Gilissen C; de Vries BB; Schenck A; Kleefstra T; Vissers LE
    Eur J Hum Genet; 2016 Aug; 24(8):1145-53. PubMed ID: 26757981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted Next-Generation Sequencing Analysis of 1,000 Individuals with Intellectual Disability.
    Grozeva D; Carss K; Spasic-Boskovic O; Tejada MI; Gecz J; Shaw M; Corbett M; Haan E; Thompson E; Friend K; Hussain Z; Hackett A; Field M; Renieri A; Stevenson R; Schwartz C; Floyd JA; Bentham J; Cosgrove C; Keavney B; Bhattacharya S; ; ; ; Hurles M; Raymond FL
    Hum Mutat; 2015 Dec; 36(12):1197-204. PubMed ID: 26350204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disruption of PHF21A causes syndromic intellectual disability with craniofacial anomalies, epilepsy, hypotonia, and neurobehavioral problems including autism.
    Kim HG; Rosenfeld JA; Scott DA; Bénédicte G; Labonne JD; Brown J; McGuire M; Mahida S; Naidu S; Gutierrez J; Lesca G; des Portes V; Bruel AL; Sorlin A; Xia F; Capri Y; Muller E; McKnight D; Torti E; Rüschendorf F; Hummel O; Islam Z; Kolatkar PR; Layman LC; Ryu D; Kong IK; Madan-Khetarpal S; Kim CH
    Mol Autism; 2019; 10():35. PubMed ID: 31649809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deletion of 3p25.3 in a patient with intellectual disability and dysmorphic features with further definition of a critical region.
    Kellogg G; Sum J; Wallerstein R
    Am J Med Genet A; 2013 Jun; 161A(6):1405-8. PubMed ID: 23613140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional convergence of histone methyltransferases EHMT1 and KMT2C involved in intellectual disability and autism spectrum disorder.
    Koemans TS; Kleefstra T; Chubak MC; Stone MH; Reijnders MRF; de Munnik S; Willemsen MH; Fenckova M; Stumpel CTRM; Bok LA; Sifuentes Saenz M; Byerly KA; Baughn LB; Stegmann APA; Pfundt R; Zhou H; van Bokhoven H; Schenck A; Kramer JM
    PLoS Genet; 2017 Oct; 13(10):e1006864. PubMed ID: 29069077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. De novo missense variants in MEIS2 recapitulate the microdeletion phenotype of cardiac and palate abnormalities, developmental delay, intellectual disability and dysmorphic features.
    Douglas G; Cho MT; Telegrafi A; Winter S; Carmichael J; Zackai EH; Deardorff MA; Harr M; Williams L; Psychogios A; Erwin AL; Grebe T; Retterer K; Juusola J
    Am J Med Genet A; 2018 Sep; 176(9):1845-1851. PubMed ID: 30055086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. De Novo Mutations Affecting the Catalytic Cα Subunit of PP2A, PPP2CA, Cause Syndromic Intellectual Disability Resembling Other PP2A-Related Neurodevelopmental Disorders.
    Reynhout S; Jansen S; Haesen D; van Belle S; de Munnik SA; Bongers EMHF; Schieving JH; Marcelis C; Amiel J; Rio M; Mclaughlin H; Ladda R; Sell S; Kriek M; Peeters-Scholte CMPCD; Terhal PA; van Gassen KL; Verbeek N; Henry S; Scott Schwoerer J; Malik S; Revencu N; Ferreira CR; Macnamara E; Braakman HMH; Brimble E; Ruzhnikov MRZ; Wagner M; Harrer P; Wieczorek D; Kuechler A; Tziperman B; Barel O; de Vries BBA; Gordon CT; Janssens V; Vissers LELM
    Am J Hum Genet; 2019 Jan; 104(1):139-156. PubMed ID: 30595372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. De novo, heterozygous, loss-of-function mutations in SYNGAP1 cause a syndromic form of intellectual disability.
    Parker MJ; Fryer AE; Shears DJ; Lachlan KL; McKee SA; Magee AC; Mohammed S; Vasudevan PC; Park SM; Benoit V; Lederer D; Maystadt I; Study D; FitzPatrick DR
    Am J Med Genet A; 2015 Oct; 167A(10):2231-7. PubMed ID: 26079862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. De novo loss-of-function mutations in X-linked SMC1A cause severe ID and therapy-resistant epilepsy in females: expanding the phenotypic spectrum.
    Jansen S; Kleefstra T; Willemsen MH; de Vries P; Pfundt R; Hehir-Kwa JY; Gilissen C; Veltman JA; de Vries BB; Vissers LE
    Clin Genet; 2016 Nov; 90(5):413-419. PubMed ID: 26752331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intellectual disability associated with craniofacial dysmorphism, cleft palate, and congenital heart defect due to a de novo MEIS2 mutation: A clinical longitudinal study.
    Gangfuß A; Yigit G; Altmüller J; Nürnberg P; Czeschik JC; Wollnik B; Bögershausen N; Burfeind P; Wieczorek D; Kaiser F; Roos A; Kölbel H; Schara-Schmidt U; Kuechler A
    Am J Med Genet A; 2021 Apr; 185(4):1216-1221. PubMed ID: 33427397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.